A bill to maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
Referred to the Subcommittee on Health.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Measure laid before Senate by unanimous consent. (consideration: CR S9613-9614)
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S9613-9614)
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S9613-9614)
Message on Senate action sent to the House.
Received in the House.
Held at the desk.
Mr. Pallone moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H10025-10026)
DEBATE - The House proceeded with forty minutes of debate on S. 4120.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10025-10026)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)
Motion to reconsider laid on the table Agreed to without objection.
Presented to President.
Presented to President.
Signed by President.
Signed by President.
Became Public Law No: 117-350.
Became Public Law No: 117-350.
Enacted as Public Law 117-350
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line